Monkeys' Paralysis Cured in InVivo Study, CEO Says

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 24 (Bloomberg) -- Frank Reynolds, chief executive officer of InVivo Therapeutics Holding, talks about the company's products to cure paralysis by repairing spinal cord tissue and the outlook for the Food and Drug Administration's approval of InVivo products. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change